Login / Signup
Gayatri Ramakrishna
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Prognostic Factors
Dendritic Cells
Ejection Fraction
Drug Delivery
Top Venues
Hepatology communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mojahidul Islam
,
Karan Kumar
,
Jayesh Kumar Sevak
,
Ankur Jindal
,
Ashish Kumar Vyas
,
Gayatri Ramakrishna
,
Shyamasundaran Kottilil
,
Manoj Kumar Sharma
,
Shiv Kumar Sarin
,
Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN.
Hepatology communications
7 (5) (2023)
Mojahidul Islam
,
Karan Kumar
,
Jayesh Kumar Sevak
,
Ankur Jindal
,
Ashish Kumar Vyas
,
Gayatri Ramakrishna
,
Shyamasundaran Kottilil
,
Manoj Kumar Sharma
,
Shiv Kumar Sarin
,
Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN.
Hepatology communications
7 (5) (2023)
Mojahidul Islam
,
Karan Kumar
,
Jayesh Kumar Sevak
,
Ankur Jindal
,
Ashish Kumar Vyas
,
Gayatri Ramakrishna
,
Shyamasundaran Kottilil
,
Manoj Kumar Sharma
,
Shiv Kumar Sarin
,
Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN.
Hepatology communications
7 (5) (2023)
Mojahidul Islam
,
Karan Kumar
,
Jayesh Kumar Sevak
,
Ankur Jindal
,
Ashish Kumar Vyas
,
Gayatri Ramakrishna
,
Shyamasundaran Kottilil
,
Manoj Kumar Sharma
,
Shiv Kumar Sarin
,
Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN.
Hepatology communications
7 (5) (2023)
Mojahidul Islam
,
Karan Kumar
,
Jayesh Kumar Sevak
,
Ankur Jindal
,
Ashish Kumar Vyas
,
Gayatri Ramakrishna
,
Shyamasundaran Kottilil
,
Manoj Kumar Sharma
,
Shiv Kumar Sarin
,
Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN.
Hepatology communications
7 (5) (2023)